Beijing Biostar Pharmaceuticals
2563 · HKEX
Public Market Listing
2563HKEX
Live quotes, historical charts, and market capitalization for Beijing Biostar Pharmaceuticals are available on Yahoo Finance.
View quote & market cap on Yahoo Finance ↗External market data link · No third-party exchange redistribution
Assets
(1 total)
1Total Assets
0Approved
1Phase 3 / Filed
0Phase 1–2 / Early
2Diseases
Quick filter:
| Target & Modality | |||
|---|---|---|---|
| Phase 3 | Tubulin / microtubulesSmall molecule | Non-Small Cell Lung CancerBreast Cancer HR+/HER2- Metastatic Breast Cancer |
Upcoming events
(6 total)
Estimated primary-completion dates from ClinicalTrials.gov and expected earnings reports. These are registry estimates, never confirmed readout dates; they can move as trials progress.
Add these trial readouts to your calendar: Apple or Outlook · Google Calendar · .ics link. The calendar updates when a registry date moves.
2026 (2)
December 2026 (2)
Est. primary completion 2026-12-01 · NCT06683703 · CT.gov ↗
What to watch
2027 (2)
January 2027 (1)
2028 (1)
Financial reports
Quarterly & interim (1)
| Period | Revenue | R&D | Cash & equiv. | Net loss / qtr | Filing |
|---|---|---|---|---|---|
| 2025-H1 | — | — | — | $7.5M | report ↗ |